ATE473241T1 - Neue hämpeptide - Google Patents
Neue hämpeptideInfo
- Publication number
- ATE473241T1 ATE473241T1 AT03743542T AT03743542T ATE473241T1 AT E473241 T1 ATE473241 T1 AT E473241T1 AT 03743542 T AT03743542 T AT 03743542T AT 03743542 T AT03743542 T AT 03743542T AT E473241 T1 ATE473241 T1 AT E473241T1
- Authority
- AT
- Austria
- Prior art keywords
- agent
- hemeptides
- new
- environment
- peptide
- Prior art date
Links
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000003278 haem Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
- C07K14/805—Haemoglobins; Myoglobins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002058086A JP4070081B2 (ja) | 2002-03-04 | 2002-03-04 | 新規ヘムペプチド |
| PCT/JP2003/002394 WO2003074564A1 (fr) | 2002-03-04 | 2003-02-28 | Nouvel hemepeptide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE473241T1 true ATE473241T1 (de) | 2010-07-15 |
Family
ID=27784682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03743542T ATE473241T1 (de) | 2002-03-04 | 2003-02-28 | Neue hämpeptide |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7358338B2 (de) |
| EP (1) | EP1489096B1 (de) |
| JP (1) | JP4070081B2 (de) |
| AT (1) | ATE473241T1 (de) |
| AU (1) | AU2003211601A1 (de) |
| DE (1) | DE60333264D1 (de) |
| WO (1) | WO2003074564A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200157188A1 (en) * | 2017-06-28 | 2020-05-21 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Synthetic heme-containing molecules and their use |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5273896A (en) | 1989-10-13 | 1993-12-28 | Novo Nordisk A/S | Hemopeptide having peroxidase activity for bleaching dyes |
-
2002
- 2002-03-04 JP JP2002058086A patent/JP4070081B2/ja not_active Expired - Fee Related
-
2003
- 2003-02-28 US US10/507,156 patent/US7358338B2/en not_active Expired - Fee Related
- 2003-02-28 AU AU2003211601A patent/AU2003211601A1/en not_active Abandoned
- 2003-02-28 DE DE60333264T patent/DE60333264D1/de not_active Expired - Lifetime
- 2003-02-28 EP EP03743542A patent/EP1489096B1/de not_active Expired - Lifetime
- 2003-02-28 WO PCT/JP2003/002394 patent/WO2003074564A1/ja not_active Ceased
- 2003-02-28 AT AT03743542T patent/ATE473241T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1489096A4 (de) | 2006-11-08 |
| US20060258563A1 (en) | 2006-11-16 |
| EP1489096B1 (de) | 2010-07-07 |
| DE60333264D1 (de) | 2010-08-19 |
| AU2003211601A1 (en) | 2003-09-16 |
| WO2003074564A1 (fr) | 2003-09-12 |
| JP4070081B2 (ja) | 2008-04-02 |
| US7358338B2 (en) | 2008-04-15 |
| JP2003252900A (ja) | 2003-09-10 |
| EP1489096A1 (de) | 2004-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0400719A2 (hu) | Vegyületek és eljárások Chlamydia-fertőzés diagnosztikájára és kezelésére | |
| EP1536012A4 (de) | Menschlicher anti-mensch-interleukin-6-antikörper sowie fragment des antikörpers | |
| ITMI20022431A1 (it) | Utensile abrasivo poroso e procedimento per la sua fabbricazione. | |
| BR0111125A (pt) | Moléculas de ácido nucléico de nrg-2, polipeptìdeos, e métodos diagnóstico e terapêuticos | |
| EP1505990A4 (de) | Verfahren zur behandlung von hepatitis | |
| IS8267A (is) | [1,8]naftýridín-2-ón og tengd efnasambönd til notkunar við meðferð á geðklofa | |
| DE60226797D1 (de) | Instrument zum Einbringen von Befestigungselementen für Transplantate | |
| ATE451390T1 (de) | Polypeptide zur bindung an das b-lymphozyten- stimulatorische protein (blys) | |
| DE60233611D1 (de) | Gassensor und Heizverfahren für diesen Gassensor | |
| DE60237242D1 (de) | Hilfsverfahren, hilfsprogramm und hilfsvorrichtung zur bildanalyse | |
| ATE465410T1 (de) | Vorrichtungen und verfahren zum nachweis von fruchtwasser in vaginalsekreten | |
| WO2003007803A3 (en) | Methods for diagnosing and treating alzheimer's disease and parkinson's disease | |
| DK1560812T3 (da) | Aminocyclohexyletherforbindelser og anvendelser deraf | |
| SG149000A1 (en) | Gag binding proteins | |
| EP1499328A4 (de) | Verfahren zur behandlung von nekrotisierender enterocolitis | |
| ATE466659T1 (de) | Probenahmesystem mit phosphataseinhibitor | |
| DE60323994D1 (de) | Verfahren zur herstellung von 2-chlor-1,1,1,2,3,3,3-heptafluorpropan, hexafluorpropen und 1,1,1,2,3,3,3-heptafluorpropan | |
| ATE319439T1 (de) | Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd | |
| MA27503A1 (fr) | Composition et methode de traitement du diabete. | |
| FI990771L (fi) | Menetelmä uloshengitetyn kaasun analysoimiseksi | |
| ATE408832T1 (de) | Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper | |
| ATE473241T1 (de) | Neue hämpeptide | |
| EP1392444A4 (de) | Verfahren zur sulfidkonzentration | |
| BRPI0416201A (pt) | métodos para purificação de toxina coqueluche e peptìdios neles utilizáveis | |
| NO20010345D0 (no) | Fremgangsmåte og anordning til behandling av gasser, samt anvendelse derav |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |